Tego Cyber (OTC:TGCB) Stock, Quote.Headers.trade-ideas

Tego Cyber Inc is engaged in the development and commercialization of cybersecurity services and solutions that reduce risk, prevent cyber-attacks and protect intellectual property and data. The products of the company are Threat Correlation, SIEM Integration, Threat Intelligence Feed, Databricks Integration and Amazon Security Lake.

Penny Stocks

Emerging Markets

Markets

Tech

CRWD

FTNT

SPLK

TGCB

Photo from Pixabay 

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Tego Cyber - A Name to Watch in Cybersecurity

Tego Cyber Inc

WIIM

MLKN

MillerKnoll shares are trading lower after the company reported worse-than-expected Q1 financial results and issued Q2 EPS guidance below estimates.

News

Guidance

SBGI

Sinclair Updates Q3 Political Advertising Revenue Guidance From $113M-$128M To $140M-$145M; Now Sees Q3 Local Media Advertising Revenue $425M-$438M, Up From Prior Expectation Of $401M-$428M

On Friday, September 13, Washington D.C. authorities shut down Green Cloud Shop, an unlicensed cannabis business, as part of a broader crackdown on illegal cannabis operations.
The Alcoholic Beverage and Cannabis Administration (ABCA), alongside the Metropolitan Police Department (MPD), <a href="https://abca.dc.gov/release/abca-shutters-illegally-operating-cannabis-business#gsc.tab=0">padlocked</a> the shop. The owner, a 49-year-old man, was arrested and charged with Possession with Intent to Distribute and Operating a Business After Certificate of Authority had been revoked.
This measure came in the context of an ongoing conflict with unregulated &#8220;gift economy&#8221; cannabis shops, which were tolerated in the past but are now being pushed to adapt to regulations, <a href="https://www.axios.com/local/washington-dc/2024/09/18/marijuana-dispensary-gifting-shops-crackdown">reported</a> Axios.
<h3 class="wp-block-heading">Say Goodbye To D.C.&#8217;s Cannabis Gifting Economy</h3>
Cannabis gifting shops in D.C. have long used a loophole by "gifting" marijuana when customers purchase other products. This allowed them to bypass laws against recreational cannabis sales, in the context of the tricky legal situation affecting Washington D.C. cannabis.
However, city officials are now stepping up enforcement. The more than 100 unlicensed shops that are currently operating are seen as a major threat to the legal medical cannabis market.
The crackdown comes after the D.C. Council green-lit an emergency bill to give city officials the authority to impose penalties on unlicensed cannabis stores <a href="https://www.benzinga.com/markets/cannabis/24/01/36597430/new-emergency-law-empowers-authorities-to-crack-down-on-cannabis-gifting-shops-in-d-c">earlier this year</a>. D.C. lawmakers, including progressive members, are backing this crackdown due to concerns about crime around all-cash businesses and the proximity of some shops to schools and daycare facilities.
<ul>
<li>Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37896144/washington-state-gov-signs-bill-eliminating-medical-marijuana-tax-iowa-to-add-25-excise-tax-on-h">Washington State Gov. Signs Bill Eliminating Medical Marijuana Tax, Iowa To Add 25% Excise Tax On Hemp &amp; More</a></li>
</ul>
<h3 class="wp-block-heading">The Latest Developments In D.C.</h3>
Green Cloud Shop's closure is part of a new wave of enforcement following the Medical Cannabis Conditional License and Unlicensed Establishment Closure Clarification Emergency Amendment Act of 2024. This law, enacted in July, grants the ABCA enhanced authority to close illegal businesses.
Green Cloud is the second illicit cannabis business closed by ABCA since the new law went into effect. 
Curiously, authorities reported padlocking the access to the store. This echoes New York&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/09/40910485/is-mayor-adams-crackdown-on-illegal-cannabis-working-nyc-council-weighs-in-after-1-000-store-clo">special operation</a> that cracked down on illicit cannabis during the first few months of the year.
In addition to the closures, the ABCA has issued 23 cease-and-desist orders and 79 warning letters to unlicensed cannabis businesses. Many shops, however, continue operating, with only a few being forced to shut down.
But still, property owners of illicit cannabis shops could face a $10,000 fine if they fail to comply with the ABCA's closure orders.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">The Struggle Of Legal D.C. Cannabis Dispensaries</h3>
The crackdown comes at a crucial time for D.C.'s legal <a href="https://www.benzinga.com/markets/cannabis/24/06/39262441/washington-provides-tax-break-for-medical-cannabis-users-but-is-it-enough">medical cannabis </a>market, which has been <a href="https://www.benzinga.com/markets/cannabis/24/07/39937544/medical-marijuana-market-in-d-c-at-risk-of-perishing-affected-business-owner-explains">struggling to compete</a> with unlicensed operators. 
Adding to the pressure, D.C. dispensaries face stiff competition from Maryland's legal recreational market, where prices are often lower. Since January 2024, D.C.'s legal market has been in a steep decline, selling less than 400 pounds of flower per month. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/06/39262441/washington-provides-tax-break-for-medical-cannabis-users-but-is-it-enough">Washington Provides Tax Break For Medical Cannabis Users, But Is It Enough?</a></li>
</ul>
Cover: Benzinga edit based on Washarapol D BinYo Jundang and Anna Lowe via Pixels

Cannabis

Government

Regulations

Politics

D.C. Continues Crackdown On Cannabis Gifting Shops: One Arrested, Store Padlocked, Although Many More Remain Open

Alternus Clean Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALCE#NASDAQ">ALCE</a>) ("Alternus" or the "Company"), a leading utility-scale transatlantic, clean energy independent power producer (IPP), has terminated its MIPSA with C2 Taiyo Fund I, LLP to acquire approximately 80MWp solar installations across 8 U.S. states, originally announced on May 1, 2024, due to seller's failure to meet the required closing conditions and fundamental changes in the portfolio of assets planned to be acquired.

Contracts

ALCE

Alternus Clean Energy Has Terminated Its MIPSA With C2 Taiyo Fund I, LLP To Acquire ~80MWp Solar Installations Across 8 U.S. States, Originally Announced On May 1, 2024, Due To Seller's Failure To Meet The Required Closing Conditions And Fundamental Changes In The Portfolio Of Assets Planned To Be Acquired

Nike shares are trading higher after the company announced Elliot Hill will take over as the new President and CEO. John Donahoe will retire from his position.

TechnipFMC Awarded Two Subsea Contracts By Petrobras For Brazil's Pre-Salt Fields; First Contract Is Between $250M-$500M And Second Is Between $75M-$250M

Earnings

GNFT

CORRECTION: Genfit H1 2024 Adj. EPS €0.53; Revenues And Other Income €61.199M

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) revealed 9 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $562,711, and 5 were calls, valued at $259,716.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $60.0 to $100.0 for Moderna during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of 2,026.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $60.0 to $100.0 over the last 30 days.
<h3>Moderna Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726777077_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$25.9</td>
<td>$24.35</td>
<td>$25.9</td>
<td>$90.00</td>
<td>$388.5K</td>
<td>1.9K</td>
<td style="text-align: right;">150</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$13.3</td>
<td>$13.25</td>
<td>$13.3</td>
<td>$70.00</td>
<td>$81.1K</td>
<td>108</td>
<td style="text-align: right;">123</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$31.0</td>
<td>$30.85</td>
<td>$31.0</td>
<td>$100.00</td>
<td>$65.1K</td>
<td>0</td>
<td style="text-align: right;">609</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$2.66</td>
<td>$2.65</td>
<td>$2.65</td>
<td>$60.00</td>
<td>$59.3K</td>
<td>1.6K</td>
<td style="text-align: right;">233</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.6</td>
<td>$3.55</td>
<td>$3.55</td>
<td>$80.00</td>
<td>$58.5K</td>
<td>702</td>
<td style="text-align: right;">536</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Following our analysis of the options activities associated with Moderna, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Moderna</h3>
<ul>
<li>Trading volume stands at 5,013,059, with MRNA's price down by -2.52%, positioned at $68.1.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 42 days.</li>
</ul>
<h3>What Analysts Are Saying About Moderna</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $82.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Sector Perform, setting a price target of $75. 
&#x2A; An analyst from RBC Capital has decided to maintain their Sector Perform rating on Moderna, which currently sits at a price target of $75. 
&#x2A; An analyst from Jefferies has revised its rating downward to Hold, adjusting the price target to $65. 
&#x2A; An analyst from HSBC upgraded its action to Hold with a price target of $82. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Moderna, targeting a price of $115. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

MRNA

Behind the Scenes of Moderna's Latest Options Trends

Offerings

KOPN

Kopin Corporation Announces Public Offering of Common Stock and Pre-Funded Warrants, Plans to Use Proceeds for Corporate Purposes and Potential Litigation Payments; Size Not Disclosed

Genfit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNFT#NASDAQ">GNFT</a>) reported quarterly earnings of $0.57 per share. This is a 226.67 percent increase over losses of $(0.45) per share from the same period last year. The company reported $63.49 million in sales this quarter. This is a 281.83 percent increase over sales of $16.63 million the same period last year.

Genfit H1 EPS $0.57 Up From $(0.45) YoY, Sales $63.49M Up From $16.63M YoY (Converted To USD)

Management

TIGO

Millicom International Cellular Appoints Maxime Lombardini As Interim Chair Of The Board

Nike Says Elliott Hill To Join Nike Board And Executive Committee

Cryptocurrency markets are trading 5.9% higher to $2.19 trillion as crypto short liquidations spiked to the highest level since Aug. 23.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$63,485.74</td>
<td>+5.3%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,467.60</td>
<td>+6.6%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$143.74</td>
<td>+10.8%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1062</td>
<td>+5%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.0000142</td>
<td>+6.3%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows a 1% drop in large transaction volume and a 5.7% decline in daily active addresses. However, exchanges netflows narrowed by 278.4%. With Bitcoin prices racing beyond the $61,000 mark, 88% of Bitcoin holders are in profit, while 12% are at breakeven.</li>
<li>Coinglass data shows 61,634 traders liquidated in the past 24 hours for $190.39 million, with short liquidations coming in at $117.6 million, the highest level since Aug. 23.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40943186/cybercriminals-busted-for-243m-crypto-heist-they-spent-hundreds-of-thousands-in-night-club">Cybercriminals Busted For $243M Crypto Heist: They Spent Hundreds Of Thousands In Night Clubs And On Luxury Gifts</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40942924/whats-going-on-with-coinbase-stock">What&#8217;s Going On With Coinbase Stock?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40944865/jade-city-to-democratize-access-to-50b-jade-market-with-tokenization-platform">Jade City To Democratize Access To $50B Jade Market With Tokenization Platform</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Popcat (SOL) (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POPCAT</a>)</td>
<td>$0.8976</td>
<td>+28.2%</td>
</tr>
<tr>
<td>Sei (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SEI</a>)</td>
<td>$0.3344</td>
<td>+19.9%</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$1.77</td>
<td>+18.5%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices chasing the $63,000 mark, Cold Blooded Shiller predicts that if this move breaks to the upside, &#8220;expect this area to be a sweep with a fast response back.&#8221; He suggests keeping note of the $61,500 level.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If we get the LTF <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> correction I think the reaction around $61.5k will be important. If this move is going to break HTF structure to the upside I&#39;d expect this area to be a sweep with a fast response back. (The good ol&#39; V-reversal days) <a href="https://t.co/0nowzEJ8dL">pic.twitter.com/0nowzEJ8dL</a>
&mdash; Cold Blooded Shiller (@ColdBloodShill) <a href="https://twitter.com/ColdBloodShill/status/1836847538164363288?ref_src=twsrc%5Etfw">September 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">Crypto trader Scient <a href="https://x.com/Crypto_Scient/status/1836849315878256780">states</a> that this is that part of cycle where Bitcoin cools off, &#8220;does a bit of correction and altcoins take the lead.&#8221; However, after Bitcoin&#8217;s consolidation, it takes the lead again, makes the next leg higher and altcoins slow down. </figcaption></figure>
Stockmoney Lizards marks this price movement as the beginning of the &#8220;final cycle pump&#8221; and expects the cycle top around September to October 2025 between $200,000 and $260,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a>: The Final Cycle Pump Begins We are entering what could be the final pump of this Bitcoin cycle. The cycle top is expected around September to October 2025. My personal price target for Bitcoin is between $200,000 and $260,000. Legend: Here, you can see the last three… <a href="https://t.co/f7BTzM8YyM">pic.twitter.com/f7BTzM8YyM</a>
&mdash; Stockmoney Lizards (@StockmoneyL) <a href="https://twitter.com/StockmoneyL/status/1836835839340597600?ref_src=twsrc%5Etfw">September 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40932192/trump-pays-up-for-smash-burgers-and-diet-cokes-with-bitcoin-during-new-york-campaign-halt-">Trump Pays Up For Smash Burgers And Diet Cokes With Bitcoin During New York Campaign Halt — Move Hailed As &#8216;One Of The Most Historic Transactions&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$POPCAT

$SEI

$SHIB

$SOL

$WIF

Bitcoin, Ethereum, Dogecoin Surge: Has The 'Final Cycle Pump' Really Started?

Nike, Inc. Board Of Directors Announces Long-time Nike Veteran Elliott Hill To Return As President And Chief Executive Officer John Donahoe To Retire From Nike

NWTN

NWTN Suspends Rabdan Vehicle Production Following UAE Authority's Directive, Rebadges 320 Vehicles, Expects $17M Inventory Impairment, Reduces Workforce by 57%, and Explores New Partnerships Amid Challenges

AENT

Alliance Entertainment shares are trading higher after the company reported better-than-expected full-year 2024 adjusted EPS results.

Financing

Simon Property Group Amended, Restated And Extended $3.5B Revolving Credit Facility

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial &nbsp;
Results to be presented at the American Heart Association (AHA) Scientific Sessions in November 2024
Phase 1b single dose hemodynamic proof-of-concept clinical trial in Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF) escalated to the highest dose of TX45 (3 mg/kg) based on favorable tolerability profile observed at lower doses, with topline trial results expected in the second quarter of 2025
WATERTOWN, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECX#NASDAQ">TECX</a>) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced favorable Phase 1a topline data for its lead asset TX45, a long-acting, potentially best-in-class relaxin. TX45 is being developed for the treatment of Group 2 PH-HFpEF.

Biotech

General

TECX

Tectonic Therapeutic Announces Phase 1a Safety, Tolerability And PK/PD Results For Lead Program TX45; TX45 Was Well-tolerated With No Observed Immunogenicity, And Demonstrated A Favorable PK/PD Relationship Which Was Used To Identify Doses For The Phase 2 Clinical Trial

Arq shares are trading lower after the company announced a proposed public offering of common stock, details not disclosed.

iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. The company reported quarterly sales of $19.500 million which missed the analyst consensus estimate of $21.300 million by 8.45 percent. This is a 16.66 percent decrease over sales of $23.399 million the same period last year.

Earnings Beats

Earnings Misses

iPower Q4 2024 Adj. EPS $0.03 Beats $0.01 Estimate, Sales $19.5M Miss $21.300M Estimate

Tego Cyber (TGCB) has issued an announcement. Tego Cyber Inc. has recently updated its investor community by posting a presentation on its website,...

Tego Cyber Shares Company Overview and Outlook

Events

Press Releases

Tego Cyber To Present at the Plant Microcap Showcase: Vegas 2024

Tego Cyber Retains Hayden IR to Provide Investor Relations Services

Tego Cyber Expands Channel Partner Network

Tego Cyber Authorized as a CVE Numbering Authority

Tego Cyber Inc. Co-Founder and Chief Technical Officer Shannon Wilkinson Receives Champion in Security: Inclusion Award at RSA

Tego Cyber Inc. To Present at the Spring Microcap Rodeo Conference

MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

Tego Cyber Inc. Announces Appointment of Jon Jensen as an Independent Director to Its Board

Tego Cyber Inc. Increases Annual Recurring Revenue Through Expanded Partnership With Brier & Thorn

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Tego Cyber

Tego Cyber (TGCB) Forecast

Tego Cyber (OTC:TGCB) Stock, Quote.Headers.trade-ideas